Friday, 12 October 2018

U.S. appeals court upholds ruling that canceled Teva Copaxone patents

A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)